List of Krystal Biotech patents

List of Krystal Biotech patents

List of Afton Chemical patents

List of Uncommon Schools patents

List of Incoe Corporation patents

List of companies in Ted Leonsis's investment portfolio

List of SBIR/STTR awards granted to MATERIAL INNOVATIONS, INCORPORATED

Patents where

Current Assignee

Name

is

Krystal Biotech

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10155016 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin	Patent 10155016 was granted and assigned to Krystal Biotech on December, 2018 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	10155016	December 18, 2018
	‌ US Patent 10441614 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin	Patent 10441614 was granted and assigned to Krystal Biotech on October, 2019 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	10441614	October 15, 2019
	‌ US Patent 9877990 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin	Patent 9877990 was granted and assigned to Krystal Biotech on January, 2018 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	9877990	January 30, 2018
	‌ US Patent 11185564 Compositions and methods for the treatment of wounds, disorders, and diseases of the skin	Patent 11185564 was granted and assigned to Krystal Biotech on November, 2021 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	11185564	November 30, 2021
	‌ US Patent 12128122 Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic	Patent 12128122 was granted and assigned to Krystal Biotech on October, 2024 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	12128122	October 29, 2024
	‌ US Patent 11642384 Compositions and methods for the treatment of Netherton Syndrome	Patent 11642384 was granted and assigned to Krystal Biotech on May, 2023 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	11642384	May 9, 2023
	‌ US Patent 10525090 Compositions and methods for the treatment of autosomal recessive congenital ichthyosis	Patent 10525090 was granted and assigned to Krystal Biotech on January, 2020 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	10525090	January 7, 2020
	‌ US Patent 10786438 Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications	Patent 10786438 was granted and assigned to Krystal Biotech on September, 2020 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	10786438	September 29, 2020
	‌ US Patent 10829529 Compositions and methods for delivering CFTR polypeptides	Patent 10829529 was granted and assigned to Krystal Biotech on November, 2020 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	10829529	November 10, 2020
	‌ US Patent 11865148 Methods of delivering transgenes to the eye	Patent 11865148 was granted and assigned to Krystal Biotech on January, 2024 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	11865148	January 9, 2024
	‌ US Patent 11779660 Viral vectors for cancer therapy	Patent 11779660 was granted and assigned to Krystal Biotech on October, 2023 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	11779660	October 10, 2023
	‌ US Patent 11918660 Viral vectors for cancer therapy	Patent 11918660 was granted and assigned to Krystal Biotech on March, 2024 by the United States Patent and Trademark Office.	Krystal Biotech	Krystal Biotech		United States Patent and Trademark Office	11918660	March 5, 2024

12 results

0 selected

12 results

0 selected